| 2002 |
Neurabin I localizes to the actin cytoskeleton via its N-terminal F-actin-binding domain and promotes disassembly of stress fibers; deletion of C-terminal coiled-coil and SAM domains abolishes dimerization and induces filopodium extension. Neurabin I recruits active PP1 via a PP1-docking sequence (457)KIKF(460), and mutation of this motif or pharmacological PP1 inhibition abolishes filopodia and restores stress fibers, establishing that the neurabin I/PP1 complex controls actin rearrangement. PKA phosphorylation of serine-461 impairs PP1 binding, and p70S6K is excluded from neurabin I/PP1 complexes, requiring PP1 displacement for its own recruitment to neurabin I. |
GFP-fusion live imaging, deletion/point mutant analysis, immune complex phosphatase assays, okadaic acid/calyculin A pharmacological inhibition, in vitro and in vivo PKA phosphorylation assays in Cos7, HEK293, and hippocampal neurons |
Molecular and cellular biology |
High |
12052877
|
| 1999 |
Neurabin I binds and inhibits PP1 (Ki = 2.7 nM for a GST-neurabin I fragment containing residues 318–661) via its PP1-binding domain (residues 456–460). PKA phosphorylates neurabin I at serine-461 (identified by HPLC-MS), significantly reducing PP1 binding and a S461E phosphomimetic mutant showed 35-fold reduced inhibitory potency, establishing a cAMP-dependent regulatory mechanism for PP1 activity and localization. |
GST pulldown, overlay assay, yeast two-hybrid, co-immunoprecipitation, in vitro PP1 activity assay, in vitro PKA phosphorylation, HPLC-MS phosphosite identification, S461E phosphomimetic mutagenesis |
Biochemistry |
High |
10504266
|
| 2002 |
Neurabin I (and neurabin II/spinophilin) preferentially recruits PP1gamma1 and PP1alpha over PP1beta from rat brain. The rank order of PP1 isoform selectivity is PP1gamma1 > PP1alpha > PP1beta. Sequences flanking the conserved PP1-binding motif and C-terminal sequences unique to PP1 isoforms together determine selectivity. In PP1gamma null mice, both neurabins show enhanced association with PP1alpha but not PP1beta, confirming isoform hierarchy in vivo. |
Immunoprecipitation from rat brain and PP1gamma null mouse brain, in vitro binding of recombinant peptides to brain extracts, chimeric neurabin and chimeric PP1/PP2A analysis, in vitro PP1 activity assay |
The Journal of biological chemistry |
High |
12016225
|
| 2007 |
Cdk5 directly phosphorylates Neurabin-I and controls its association with F-actin. Gain and loss of Neurabin-I expression affect neuronal morphology, neurite outgrowth, Rac1 activation, and radial migration of cortical neurons. Mutation of the Cdk5 phosphorylation site reduces the morphological and migratory phenotypic consequences of Neurabin-I overexpression both in vitro and in vivo, demonstrating that Cdk5-mediated phosphorylation regulates Neurabin-I function in the actin cytoskeleton during corticogenesis. |
In vitro kinase assay (Cdk5 phosphorylation), phosphorylation-site mutagenesis, antisense/overexpression in primary cortical neurons and in utero electroporation (in vivo), F-actin co-sedimentation, Rac1 activity assay |
Molecular biology of the cell |
High |
17699587
|
| 2006 |
Neurabin I is a direct binding partner of Rac3 (a neuronal Rho-family GTPase), identified by yeast two-hybrid. Neurabin I co-partitions and co-localizes with Rac3 at growth cones, and Neurabin I antisense oligonucleotides abolish Rac3-induced neuritogenesis, which is rescued by exogenous Neurabin I but not by a Neurabin I mutant lacking the Rac3-binding domain, establishing Neurabin I as a required mediator of Rac3-induced neuritogenesis by anchoring Rac3 to growth cone F-actin. |
Yeast two-hybrid, biochemical co-fractionation, co-localization by light microscopy, antisense knockdown, domain-deletion rescue experiments in primary neurons |
Molecular biology of the cell |
Medium |
16525025
|
| 1999 |
Bau, a splice form of Neurabin-I lacking actin- and p70S6K-binding domains but retaining coiled-coil domains, interacts with the tumor suppressor Bin1 (interaction requires the U3 region alternately spliced in muscle cells), localizes to the nucleus and cytosol, and suppresses oncogene-mediated transformation and inhibits tumor cell growth. |
Protein interaction screen (Bin1-based), domain-deletion analysis, subcellular localization, transformation suppression assay |
Cell adhesion and communication |
Low |
10427963
|
| 2018 |
Neurabin-I is atypically hyper-N-glycosylated at ASN1277, rendering it immunogenic and enabling it to act as a B-cell receptor autoantigen in primary CNS lymphoma (PCNSL); this modified neurabin-I induces BCR pathway activation and proliferation of lymphoma cell lines transfected with neurabin-I-reactive BCRs, and a BCR-binding epitope of neurabin-I conjugated to Pseudomonas exotoxin killed lymphoma cells expressing the respective BCRs. |
Identification of N-glycosylation site (ASN1277) by mass spectrometry/sequencing, BCR transfection into lymphoma cell lines, BCR signaling and proliferation assays, immunotoxin cytotoxicity assay |
Blood |
Medium |
30249786
|